Screener
Twist Bioscience Corporation TWST Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (In thousands, except per share data) | March 31,2026 | September 30,2025 |
|---|---|---|
| Cash and cash equivalents | $122,670 | $183,049 |
| Short-term investments | 49,001 | 49,385 |
| Accounts receivable, net[1] | 64,153 | 57,019 |
| Inventories | 33,515 | 28,309 |
| Prepaid expenses and other current assets[1] | 54,100 | 15,204 |
| Total current assets | $323,439 | $332,966 |
| Property and equipment, net | 111,226 | 102,283 |
| Operating lease right-of-use assets | 70,655 | 49,377 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's inventories?
- Twist Bioscience Corporation (TWST) reported inventories of $33.52M in Q1 2026.
- How has Twist Bioscience Corporation's inventories changed year-over-year?
- Twist Bioscience Corporation's inventories increased by 60.7% year-over-year, from $20.86M to $33.52M.
- What is the long-term trend for Twist Bioscience Corporation's inventories?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's inventories has grown at a -2.9% compound annual growth rate (CAGR), from $31.8M to $28.31M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Twist Bioscience Corporation's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude